Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Social Diagnostics Start-Up to Provide Simple, Affordable Tests Worldwide

By LabMedica International staff writers
Posted on 18 Aug 2014
The Royal Tropical Institute (KIT; Amsterdam, Netherlands) is establishing a nonprofit, social diagnostics company that develops and markets tests for the diagnosis of poverty-related diseases.

Infectious diseases have a global impact; they take no account of national borders and influence the stability of societies in matters of health and development. More...
Paul Klatser, unit manager at KIT Biomedical Research and Donald Kalff, investor and formerly a director at KLM and Shell, have joined forces in taking the initiative to establish "OneDiagnostics," with the ambition to improve the health of disadvantaged people worldwide. “I consider it a moral obligation to develop and share this type of knowledge. Both the private sector and governments are failing with regard to their support. In the Netherlands it is inconceivable to prescribe antibiotics for a fever without first having been examined by a doctor. This is however often the case in low- and middle-income countries. Not only does this leave people to remain ill or even die, it also increasingly leads to antibiotic resistance," said Mr. Klatser.

"In the ‘Western world’ we have the knowledge to treat most diseases effectively—with a timely diagnosis. The required medicines are affordable and available, also in low- and middle-income countries" said Mr. Klatser. "We are not restricting ourselves to only developing simple tests. We will also market them and invest in the correct provision of information about diagnostics and treatment, and our ultimate goal is local development and production.”

OneDiagnostics expects to need EUR 2.5 million for the start-up of the company. This would make it possible to market the first tests for brucellosis, leptospirosis, typhoid fever, and leishmaniasis. There are more plans, such as low-cost tests for tuberculosis, malaria, and a combined test for HIV and syphilis, especially intended for pregnant women in developing countries.

“We have a business plan and are now working hard to find funds to make a good start and we hope that investors will receive a small financial return in the future," said Mr. Klatser, "We will provide affordable, quality products with honest, scientifically substantiated information. The real benefit lies in the difference that OneDiagnostics will make with respect to the health of millions.”

Related Links:

Royal Tropical Institute (KIT)



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The automated multiplex PCR assay runs on the BioFire Spotfire Vaginitis System, bringing molecular vaginitis testing to the point of care (Photo courtesy of bioMérieux)

Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use

Vaginitis affects most women at least once in their lifetime and can cause painful, disruptive symptoms. Common causes include bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, reflecting... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: The CE-marked software IVD combines digital histopathology and clinicopathological data to generate a prognostic classification (Image Credit: Shutterstock)

Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.